Kelly M. Hotchkiss

Kelly M. Hotchkiss

Auto-generated profile, based on publicly available information

Kelly M. Hotchkiss

The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery Duke University Medical Center Durham North Carolina USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in The Lancet Oncology
Verified
Journal Article
Closed access
KHKelly M Hotchkiss
Kelly M Hotchkiss
PKPhilipp Karschnia
Philipp Karschnia
KSKarisa C. Schreck
Karisa C. Schreck
MGMarjolein Geurts
Marjolein Geurts
TCTimothy F Cloughesy
Timothy F Cloughesy
MKMustafa Khasraw
Mustafa Khasraw

21 November 2025 in Clinical Cancer Research
Verified
Journal Article
Open access
AMAlexandra Miggelbrink
Alexandra Miggelbrink
JPJessica Waibl Polania
Jessica Waibl Polania
LWLuke Wachsmuth
Luke Wachsmuth
SLSelena Lorrey
Selena Lorrey
AMAditya Mohan
Aditya Mohan
Peter FecciPeter Fecci
Peter Fecci
Purpose: Exhaustion represents a collection of programmed T-cell differentiation states and an important mode of T-cell dysfunction. T-cell progression from progenitor to terminal exhaustion is associated with upregulation of the transcription factor thymocyte selection–associated HMG box (TOX). Our understanding of factors regulating TOX expression and the transition from progenitor to terminal exhaustion, however, remains incomplete. Experimental Design: Single-cell RNA sequencing was used to evaluate the expression of TNF receptors on human and murine tumor-infiltrating CD8+ T cells. Flow cytometry was utilized to assess exhaustion markers and TNF receptors on CD8+ T cells. Bulk RNA sequencing was used to demonstrate the role of TNFR2 on the overall exhaustion profile. Finally, the effect of TNFR2 on the overall antitumor response was established using TNFR2-knockout (KO) mice and an antagonist. Results: We reveal that upregulation of TNFR2 coincides with the gain of phenotypic markers and functions reflective of terminal exhaustion. Loss of TNFR2 affords a novel population of T cells that expresses TIM3 but possesses diminished TOX levels and contains functional characteristics of both progenitor and terminally exhausted cells. TIM3+ TNFR2-KO T cells exhibit reduced exhaustion transcriptional programs and enhanced AP1 pathway signatures. Finally, TNFR2-KO mice demonstrate improved T cell–dependent control of tumor and chronic lymphocytic choriomeningitis infection, whereas pharmacologic antagonism of TNFR2 licenses responses to checkpoint blockade in multiple subcutaneous and intracranial tumor models. Conclusions: Our data place TNFR2 signaling as a potential upstream regulator of TOX expression in T cells and propose TNFR2 antagonism as a novel immunotherapeutic strategy.

8 October 2021 in Materialia
Verified
Journal Article
Closed access
JAJefferson O Abaricia
Jefferson O Abaricia
AWAlexander J Whitehead
Alexander J Whitehead
SKSuraj Kandalam
Suraj Kandalam
ASArth H. Shah
Arth H. Shah
KHKelly M Hotchkiss
Kelly M Hotchkiss
RORene Olivares-Navarrete
Rene Olivares-Navarrete

23 July 2026 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
DADelaney M. Anani-Wolf
Delaney M. Anani-Wolf
EMEliese M. Moelker
Eliese M. Moelker
SWShannon E. Wallace
Shannon E. Wallace
RRRachael A. Reesman
Rachael A. Reesman
KHKelly M. Hotchkiss
Kelly M. Hotchkiss
KAKatayoun (Kathy) Ayasoufi
Katayoun (Kathy) Ayasoufi
Bone marrow is a primary immune organ responsible for hematopoiesis, yet its role in shaping adaptive immune responses remains incompletely understood. In

17 February 2026
Verified
Other
Open access
AMAlexandra Miggelbrink
Alexandra Miggelbrink
JPJessica Waibl Polania
Jessica Waibl Polania
LWLuke Wachsmuth
Luke Wachsmuth
SLSelena Lorrey
Selena Lorrey
AMAditya Mohan
Aditya Mohan
Peter FecciPeter Fecci
Peter Fecci
Bulk RNA sequencing log2 fold change and adjusted p-values between WT and KO samples per gene.

4 September 2026 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
DADerek Avery
Derek Avery
LSLuke Sheakley
Luke Sheakley
MGMadison Gary
Madison Gary
SDSanjana Davis
Sanjana Davis
LCLAIS CARVALHO
LAIS CARVALHO
RORene Olivares‐Navarrete
Rene Olivares‐Navarrete